0001062993-23-019852.txt : 20231030 0001062993-23-019852.hdr.sgml : 20231030 20231030164918 ACCESSION NUMBER: 0001062993-23-019852 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231026 FILED AS OF DATE: 20231030 DATE AS OF CHANGE: 20231030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STEER RANDOLPH C CENTRAL INDEX KEY: 0001198762 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 231360977 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-10-26 0000842023 BIO-TECHNE Corp TECH 0001198762 STEER RANDOLPH C 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 1 0 0 0 0 Common Stock 2023-10-26 4 A 0 1625 0 A 24201 D Stock Options (Right to Buy) 21.84 2016-10-29 2025-10-28 Common Stock 17040 17040 D Stock Options (Right to Buy) 25.30 2017-10-26 2026-10-26 Common Stock 15940 15940 D Stock Options (Right to Buy) 31.26 2018-10-25 2027-10-26 Common Stock 12500 12500 D Stock Options (Right to Buy) 44.96 2019-10-24 2028-10-25 Common Stock 7592 7592 D Stock Options (Right to Buy) 50.41 2020-10-24 2029-10-24 Common Stock 8044 8044 D Stock Options (Right to Buy) 63.92 2021-10-28 2030-10-29 Common Stock 6028 6028 D Stock Options (Right to Buy) 128.81 2022-10-27 2031-10-28 Common Stock 2532 2532 D Stock Options (Right to Buy) 73.94 2023-10-26 2032-10-27 Common Stock 3460 3460 D Stock Options (Right to Buy) 61.51 2023-10-26 4 A 0 3937 0 A 2033-10-26 Common Stock 3937 3937 D The option vests on the earlier of the one year anniversary of the grant date (10/26/23) or the date of Bio-Techne's 2024 annual meeting of shareholders. On November 28, 2022, the Company completed a four-for-one stock split. All common stock amounts and exercise prices in the filing relating to securities acquired prior to November 28, 2022 have been adjusted to reflect the four-for-one stock split. /s/ Andrew Nick as Attorney-in-Fact for Randolph C. Steer pursuant to Power of Attorney previously filed 2023-10-30